Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Mouw

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Nature Reviews. Urology|October 31, 2025
Optimizing local control in the surgical management of bladder cancerMartin Egger, Vincent D D'Andrea, Clara Steiner, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancerKent W Mouw, Daniel J Haraf, Kerstin M Stenson, et al.
Cancer|February 20, 2020
Validation of a subclassification for high-risk prostate cancer in a prospective cohortSantino S Butler, Edward C Dee, Nayan Lamba, et al.
Practical Radiation Oncology|December 19, 2020
Association Between Travel Distance and Use of Postoperative Radiation Therapy Among Men With Organ-Confined Prostate Cancer: Does Geography Influence Treatment Decisions?Melaku A Arega, David D Yang, Trevor J Royce, et al.
Science Advances|February 18, 2022
<i>RB1</i> loss overrides PARP inhibitor sensitivity driven by <i>RNASEH2B</i> loss in prostate cancerChenkui Miao, Takuya Tsujino, Tomoaki Takai, et al.
Anticancer Research|July 20, 2021
Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder CancerCroix C Fossum, Yin Xiong, Anthony Magliocco, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2019
Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate CancerVinayak Muralidhar, Jingbin Zhang, Qiqi Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Paul L Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder CancerJudit Börcsök, Miklos Diossy, Zsofia Sztupinszki, et al.
Cancer|April 27, 2021
Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled TrialSantino S Butler, Brandon A Mahal, Javid J Moslehi, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Nature Reviews. Urology|October 31, 2025
Optimizing local control in the surgical management of bladder cancerMartin Egger, Vincent D D'Andrea, Clara Steiner, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancerKent W Mouw, Daniel J Haraf, Kerstin M Stenson, et al.
Cancer|February 20, 2020
Validation of a subclassification for high-risk prostate cancer in a prospective cohortSantino S Butler, Edward C Dee, Nayan Lamba, et al.
Practical Radiation Oncology|December 19, 2020
Association Between Travel Distance and Use of Postoperative Radiation Therapy Among Men With Organ-Confined Prostate Cancer: Does Geography Influence Treatment Decisions?Melaku A Arega, David D Yang, Trevor J Royce, et al.
Science Advances|February 18, 2022
<i>RB1</i> loss overrides PARP inhibitor sensitivity driven by <i>RNASEH2B</i> loss in prostate cancerChenkui Miao, Takuya Tsujino, Tomoaki Takai, et al.
Anticancer Research|July 20, 2021
Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder CancerCroix C Fossum, Yin Xiong, Anthony Magliocco, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2019
Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate CancerVinayak Muralidhar, Jingbin Zhang, Qiqi Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Paul L Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder CancerJudit Börcsök, Miklos Diossy, Zsofia Sztupinszki, et al.
Cancer|April 27, 2021
Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled TrialSantino S Butler, Brandon A Mahal, Javid J Moslehi, et al.
Pageof 13